Ad is loading...
FMPTX vs JVMCX
FMPTX vs JVMCX Comparison
Open Charts FMPTX vs JVMCX
Fidelity Advisor Mid Cap Value M
Price$27.32
Change+$0.42 (+1.56%)
VolumeN/A
Net Assets1.75B
JHancock Disciplined Value Mid Cap C
Price$25.22
Change+$0.29 (+1.16%)
VolumeN/A
Net Assets21.11B
FMPTX vs JVMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FMPTX vs. JVMCX commentary
Apr 03, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMPTX is a Buy and JVMCX is a Buy.
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 21.1B vs. FMPTX (1.75B). FMPTX pays higher dividends than JVMCX: FMPTX (0.43) vs JVMCX (0.00). FMPTX was incepted earlier than JVMCX: FMPTX (18 years) vs JVMCX (14 years). JVMCX (1.88) is less costly to investors than FMPTX (1.41). FMPTX is a more actively managed with annual turnover of: 78.00 vs. JVMCX (47.00). FMPTX has a lower initial minimum investment than JVMCX: FMPTX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -10.16 vs. FMPTX (-13.56). FMPTX return over 5 years is better than : 90.98 vs. JVMCX (79.77).
| FMPTX | JVMCX | FMPTX / JVMCX | |
| Total Expense Ratio | 1.41 | 1.87 | 75% |
| Annual Report Gross Expense Ratio | 1.41 | 1.88 | 75% |
| Fund Existence | 18 years | 14 years | - |
| Gain YTD | -8.510 | -1.462 | 582% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.75B | 21.1B | 8% |
| Annual Yield % from dividends | 0.43 | 0.00 | - |
| Returns for 1 year | -13.56 | -10.16 | 133% |
| Returns for 3 years | -2.09 | -4.83 | 43% |
| Returns for 5 years | 90.98 | 79.77 | 114% |
| Returns for 10 years | 12.66 | 21.87 | 58% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XBI | 80.59 | 2.43 | +3.11% |
| SPDR® S&P Biotech ETF | |||
| AMUB | 20.83 | 0.37 | +1.81% |
| UBS ETRACS Alerian MLP ETN Series B | |||
| CHI | 9.78 | 0.04 | +0.41% |
| Calamos Convertible Opportunities and Income Fund | |||
| UIVM | 51.30 | N/A | N/A |
| VictoryShares International Val MomtETF | |||
| WBND | 20.02 | -0.05 | -0.26% |
| Western Asset Total Return ETF | |||